Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation

Stock Information for Fractyl Health, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Fractyl Health, Inc.

Class Action Filed by Pomerantz LLP Against Fractyl Health, Inc. - GUTS
GUTS UPCOMING DEADLINE: Levi & Korsinsky Alerts Fractyl Health, Inc. Stockholders of Securities Class Action - Contact the Firm
Fractyl Health, Inc. (GUTS) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 20, 2026
Class Action Litigation Now Underway by Pomerantz LLP Against Fractyl Health, Inc. - GUTS
Recover Investment Losses: Class Action Initiated Against Fractyl Health, Inc. (GUTS)
Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Securities Class Action Lawsuit Filed Against Fractyl Health, Inc. (GUTS) - Levi & Korsinsky Represents Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.